IP Library › Granted Patent US 10,390,874
Granted Patent B2
US 10,390,874 · App. 15/036,393 · Granted Aug 27, 2019

Methods, systems, and apparatuses for tissue ablation using electrolysis and permeabilization

Inventors: Boris Rubinsky (El Cerrito, CA); Paul Mikus (Coto de Caza, CA); Liel Rubinsky (El Cerrito, CA)
Assignee: RM2 TECHNOLOGY LLC
A61B18/12A61B18/02A61B18/04A61B18/1492A61M1/0088A61M25/104A61N1/0502A61N1/08A61N1/32A61N1/325A61N1/327A61N1/362C25B1/26C25B9/06C25B11/04A61B18/16A61B2018/00333A61B2018/00404A61B2018/00434A61B2018/00452A61B2018/00464A61B2018/00482A61B2018/00517A61B2018/00547A61B2018/00577A61B2018/00613A61B2018/00827A61B2018/00892A61B2018/143A61B2018/1425A61M2025/105A61M2025/1052A61M2205/054A61M2205/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,390,874
App. No.
15/036,393
Granted
Aug 27, 2019
Kind
B2
Abstract

Example apparatuses and systems are disclosed for providing controlled delivery of electrolysis treatment and cellular permeabilization treatment to a site in tissue. A system disclosed may include an electrode, a power supply, and a controller. The controller may control a charge applied to the electrode to induce a direct current through the aqueous matrix to produce electrolysis products and a voltage to produce electroporation. The duration and magnitude of the charge applied may determine the dose of the products and the degree of the permeabilization of cells in the treatment site. The composition of the electrodes may be chosen in accordance with the desired products produced and electroporation effects. An apparatus is disclosed that may be in the form of electrodes the electrolysis and electrodes for electroporation applied to the tissue. An apparatus is disclosed that may be used for treating internal tissue.

Claims (38)

1. A method for tissue ablation, the method comprising:

permeabilizing cell membranes in the tissue; and

performing electrolysis to deliver electrons to and remove electrons from the tissue thereby generating products of electrolysis in the tissue, wherein said products of electrolysis are toxic to cells in the tissue.

2. The method of claim 1 , wherein said permeabilizing comprises performing electroporation.

3. The method of claim 1 , wherein said permeabilizing occurs before, during, or after said performing electrolysis, or combinations thereof.

4. The method of claim 1 , wherein said permeabilizing comprises performing cryosurgery, freezing, cold-poration, heat-poration, sonic-poration, chemo-poration or combinations thereof.

5. The method of claim 1 , wherein said products of electrolysis comprise hypochlorous acid.

6. The method of claim 1 , wherein said performing electrolysis comprises applying at least one electrode to the tissue, wherein the products of electrolysis are formed from ions in the tissue using the electrodes to deliver electrons to and remove electrons from the ions in the tissue.

7. The method of claim 1 , wherein said performing electrolysis comprises providing an electrical signal using a controller to a device configured to generate the electrons delivered to the tissue, wherein the device is positioned proximate the tissue.

8. The method of claim 7 , wherein the controller is coupled to a power supply, and the power supply is configured to provide a current to the device.

9. The method of claim 8 , wherein the current delivers the electrons and the electrical signal controls timing and magnitude of the current to generate a sufficient amount of products of electrolysis to ablate permeabilized cells in the tissue.

10. The method of claim 1 , wherein said performing electrolysis and permeabilizing cell membranes utilize a same device.

11. The method of claim 10 , wherein the same device comprises an electrode.

12. The method of claim 1 , wherein said performing electrolysis and permeabilizing cell membranes utilize a same power supply.

13. The method of claim 1 , wherein an extent of the tissue ablation is determined, at least in part, by said permeabilizing.

14. The method of claim 1 , further comprising measuring a pH in the tissue, wherein the pH is indicative of a desired extent of ablation by products of electrolysis.

15. The method of claim 1 , further comprising measuring an electric field through the tissue, wherein the electric field is indicative of permeabilizing of the tissue.

16. The method of claim 1 , wherein permeabilizing and performing electrolysis comprise applying an electric field of at least 100 V/cm for a period of time that is equal or less than 30 minutes.

17. The method of claim 1 , wherein permeabilizing includes applying an electric field of at least 100 V and wherein performing electrolysis includes applying a direct current of at least 9 mA.

18. The method of claim 17 , wherein the electric field is applied for a period of time that is equal or less than 168 seconds.

19. An apparatus for tissue ablation, the apparatus comprising:

a source of products of electrolysis, wherein the source is configured to generate products of electrolysis through an electrochemical reaction of electrolysis by delivering electrons to or removing electrons from ions in the tissue, and the source is positioned proximal the tissue; and

a device configured to permeabilize cell membranes in the tissue.

20. The apparatus of claim 19 , wherein the device configured to permeabilize cell membranes in the tissue comprises an electroporation device.

21. The apparatus of claim 19 , wherein the device configured to permeabilize cell membranes in the tissue comprises a sonicator.

22. The apparatus of claim 19 , wherein the device configured to permeabilize cell membranes in the tissue comprises a cryosurgery device.

23. The apparatus of claim 19 , further comprising a device configured to perform at least one of cryosurgery, freezing, cold-poration, heat-poration, sonic-poration, and chemo-poration.

24. The apparatus of claim 19 , wherein the source of products of electrolysis comprises two electrodes and the tissue.

25. The apparatus of claim 24 , wherein the two electrodes comprise two monopolar needle electrodes, one bipolar or multipolar needle, two surface electrodes, one surface and one needle electrode, two point electrodes, one point electrode and one needle electrode, one point electrode and one surface electrode or combinations thereof.

26. The apparatus of claim 19 , wherein the source of products of electrolysis comprises an electrode and wherein the device configured to permeabilize cell membranes also comprises the electrode.

27. The apparatus of claim 19 , wherein the tissue comprises a tumor.

28. The apparatus of claim 19 , wherein the tissue comprises prostate, breast, blood vessel, urethra, bladder, GI tract, nerve, skin, fat, or combinations thereof.

29. The apparatus of claim 19 , further comprising a pump to flush a portion of the products of electrolysis away from the tissue.

30. The apparatus of claim 19 , further comprising a reservoir coupled to the source of products of electrolysis for introduction of further compounds.

31. The apparatus of claim 19 , wherein the source of products of electrolysis comprises an electrode, and wherein the apparatus further comprises a sensor to monitor pH at the electrode.

32. The apparatus of claim 19 , wherein the device is configured to apply an electric field of at least 100 V/cm for a period of time that is equal or less than 30 minutes.

33. The apparatus of claim 19 , wherein the device is configured to apply an electric field of at least 100 V and apply a direct current of at least 9 mA.

34. The apparatus of claim 33 , wherein the electric field is applied for a period of time that is equal or less than 168 seconds.

Continuity (4)
Provisional Application 61904142 · Nov 14, 2013
Provisional Application 61921084 · Dec 27, 2013
Provisional Application 61938623 · Feb 11, 2014
Related Publication 20160296269A1 · Oct 13, 2016
Cited By (2)
US 12,209,318 US 12,564,436